
|Articles|December 1, 2006
Case report highlights rationale for neovascular glaucoma treatment
Denver-Intravitreal bevacizumab (Avastin, Genentech) proved to be a successful treatment in a patient with neovascular glaucoma.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
2
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
3
Dompé initiates phase 3 Orunea trial of cenegermin-bkbj in PCED
4
Heidelberg Engineering announces FDA clearance for new SPECTRALIS software release
5





















